Here, we demonstrate that IRF1 acts as a critical modulator in transforming macrophages into lipid-laden foam cells, and provide novel evidence explaining the link between subclinical endotoxemia and foam cell transformation. This evidence concerns the gene IRF1 and serum lipopolysaccharide activity.